10646-1-AP
antibody from Proteintech Group
Targeting: HIF1AN
DKFZp762F1811, FIH1, FLJ20615, FLJ22027
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10646-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10646-1-AP, RRID:AB_2232963
- Product name
- HIF1AN antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated HIF1AN antibody (Cat. #10646-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development.
Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.
Lai MC, Zhu QQ, Xu J, Zhang WJ
American journal of cancer research 2021;11(9):4175-4198
American journal of cancer research 2021;11(9):4175-4198
Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.
Huang J, Yu M, Yin W, Liang B, Li A, Li J, Li X, Zhao S, Liu F
Bioactive materials 2021 Sep;6(9):2841-2853
Bioactive materials 2021 Sep;6(9):2841-2853
No comments: Submit comment
No validations: Submit validation data